Human papillomavirus DNA detection, p16


Journal

Oral oncology
ISSN: 1879-0593
Titre abrégé: Oral Oncol
Pays: England
ID NLM: 9709118

Informations de publication

Date de publication:
04 2019
Historique:
received: 04 01 2019
revised: 27 02 2019
accepted: 01 03 2019
entrez: 31 3 2019
pubmed: 31 3 2019
medline: 29 4 2020
Statut: ppublish

Résumé

The role of HPV in oral cavity cancers was investigated using two markers of viral exposure. HPV DNA and p16 HPV DNA was detected in 38 of 122 (31%) oral cavity tumors. Seven genotypes were detected including HPV 16, which was found in 22% of tumors. p16 Based on both HPV DNA and p16

Identifiants

pubmed: 30926069
pii: S1368-8375(19)30073-9
doi: 10.1016/j.oraloncology.2019.03.001
pmc: PMC6498424
mid: NIHMS1020372
pii:
doi:

Substances chimiques

DNA, Viral 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

92-96

Subventions

Organisme : Intramural CDC HHS
ID : CC999999
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA071789
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA086862
Pays : United States

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Références

J Natl Cancer Inst. 2015 Apr 29;107(6):djv086
pubmed: 25925419
Radiother Oncol. 2014 Dec;113(3):310-6
pubmed: 25544647
IARC Monogr Eval Carcinog Risks Hum. 2007;90:1-636
pubmed: 18354839
J Clin Oncol. 2011 Nov 10;29(32):4294-301
pubmed: 21969503
N Engl J Med. 2010 Jul 1;363(1):24-35
pubmed: 20530316
Oncotarget. 2013 Nov;4(11):1864-5
pubmed: 24192550
J Low Genit Tract Dis. 2012 Oct;16(4):471-9
pubmed: 22652576
J Natl Cancer Inst. 2008 Feb 20;100(4):261-9
pubmed: 18270337
Oral Oncol. 2017 Apr;67:146-152
pubmed: 28351569
Hum Pathol. 2005 Jul;36(7):812-20
pubmed: 16084952
J Natl Cancer Inst. 1993 Mar 17;85(6):465-73
pubmed: 8445674
Cancer Res. 2015 Jun 15;75(12):2468-77
pubmed: 25873485
Lancet Oncol. 2014 Nov;15(12):1319-31
pubmed: 25439690
Pharmacol Res. 2013 Mar;69(1):137-43
pubmed: 23201354
Vaccine. 2006 Aug 31;24 Suppl 3:S3/1-10
pubmed: 16949995
Head Neck. 2012 Apr;34(4):459-61
pubmed: 22180304
Int J Cancer. 2013 Apr 1;132(7):1565-71
pubmed: 22949073
N Engl J Med. 2007 May 10;356(19):1944-56
pubmed: 17494927
Oral Oncol. 2014 May;50(5):370-9
pubmed: 24331868
J Clin Oncol. 2008 Feb 1;26(4):612-9
pubmed: 18235120
J Mol Diagn. 2011 Jul;13(4):377-81
pubmed: 21704270
Emerg Infect Dis. 2014 May;20(5):822-8
pubmed: 24751181
J Natl Cancer Inst. 2008 Mar 19;100(6):407-20
pubmed: 18334711
J Natl Cancer Inst. 2016 Jan 28;108(6):djv403
pubmed: 26823521
Genome Biol. 2012 Jun 14;13(6):R42
pubmed: 22698087
Oral Oncol. 2016 Oct;61:55-61
pubmed: 27688105
Cancer Res. 1988 Jun 1;48(11):3282-7
pubmed: 3365707
J Natl Cancer Inst. 2007 Dec 5;99(23):1801-10
pubmed: 18042931

Auteurs

Brenda Y Hernandez (BY)

University of Hawaii Cancer Center, University of Hawaii, Honolulu, HI, USA. Electronic address: brenda@cc.hawaii.edu.

Charles F Lynch (CF)

Department of Epidemiology, College of Public Health, The University of Iowa, Iowa City, IA, USA.

Owen T M Chan (OTM)

University of Hawaii Cancer Center, University of Hawaii, Honolulu, HI, USA.

Marc T Goodman (MT)

Cedars-Sinai Medical Center, Los Angeles, CA, USA.

Elizabeth R Unger (ER)

Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Martin Steinau (M)

Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Trevor D Thompson (TD)

Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Maura Gillison (M)

The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Christopher Lyu (C)

Rho Federal Systems Division, Inc, Chapel Hill, NC, USA.

Mona Saraiya (M)

Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH